ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P23352


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name KALM_HUMAN
Primary accession number P23352
Secondary accession numbers None
Integrated into Swiss-Prot on November 1, 1991
Sequence was last modified on March 6, 2007 (Sequence version 3)
Annotations were last modified on    June 16, 2009 (Entry version 102)
Name and origin of the protein
Protein name Anosmin-1 [Precursor]
Synonyms Kallmann syndrome protein
Adhesion molecule-like X-linked
Gene name
Name: KAL1
Synonyms: ADMLX, KAL, KALIG1
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-534.
DOI=10.1016/0092-8674(91)90193-3; PubMed=1913827 [NCBI, ExPASy, EBI, Israel, Japan]
Legouis R., Hardelin J.-P., Levilliers J., Claverie J.-M., Compain S., Wunderle V., Millasseau P., le Paslier D., Cohen D., Caterina D., Bougueleret L., Delemarre-Van de Waal H., Lutfalla G., Weissenbach J., Petit C.;
"The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules.";
Cell 67:423-435(1991).
[2]
SEQUENCE REVISION.
DOI=10.1038/ng1292-305; PubMed=1303284 [NCBI, ExPASy, EBI, Israel, Japan]
del Castillo I., Cohen-Salmon M., Blanchard S., Lutfalla G., Petit C.;
"Structure of the X-linked Kallmann syndrome gene and its homologous pseudogene on the Y chromosome.";
Nat. Genet. 2:305-310(1992).
[3]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-534.
DOI=10.1038/353529a0; PubMed=1922361 [NCBI, ExPASy, EBI, Israel, Japan]
Franco B., Guioli S., Pragliola A., Inceri B., Bardoni B., Tonlorenzi R., Carrozo R., Maestrini E., Pieretti M., Taillon-Miller P., Brown C.J., Willard H.F., Lawrence C., Persico N.G., Camerino G., Ballabio A.;
"A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules.";
Nature 353:529-536(1991).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/990031; PubMed=10591208 [NCBI, ExPASy, EBI, Israel, Japan]
Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A., Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C., Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L., Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L., Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N., Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R., Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y., Wright H.;
"The DNA sequence of human chromosome 22.";
Nature 402:489-495(1999).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-71.
DOI=10.1016/0378-1119(95)00481-K; PubMed=7590336 [NCBI, ExPASy, EBI, Israel, Japan]
Cohen-Salmon M., Tronche F., del Castillo I., Petit C.;
"Characterization of the promoter of the human KAL gene, responsible for the X-chromosome-linked Kallmann syndrome.";
Gene 164:235-242(1995).
[6]
CHARACTERIZATION.
PubMed=8832397 [NCBI, ExPASy, EBI, Israel, Japan]
Soussi-Yanicostas N., Hardelin J.-P., del Mar Arroyo-Jimenez M., Ardouin O., Legouis R., Levilliers J., Traincard F., Betton J.-M., Cabanie L., Petit C.;
"Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system.";
J. Cell Sci. 109:1749-1757(1996).
[7]
VARIANT KAL1 LYS-267, AND VARIANT ILE-534.
DOI=10.1093/hmg/2.4.373; PubMed=8504298 [NCBI, ExPASy, EBI, Israel, Japan]
Hardelin J.-P., Levilliers J., Blanchard S., Carel J.-C., Leutenegger M., Pinard-Bertelletto J.-P., Bouloux P., Petit C.;
"Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome.";
Hum. Mol. Genet. 2:373-377(1993).
[8]
VARIANT KAL1 LEU-517, AND VARIANTS ILE-534 AND HIS-668.
DOI=10.1210/jc.82.1.213; PubMed=8989261 [NCBI, ExPASy, EBI, Israel, Japan]
Georgopoulos N.A., Pralong F.P., Seidman C.E., Seidman J.G., Crowley W.F. Jr., Vallejo M.;
"Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency.";
J. Clin. Endocrinol. Metab. 82:213-217(1997).
[9]
VARIANT KAL1 LYS-514, AND VARIANT ILE-534.
DOI=10.1210/jc.83.5.1650; PubMed=9589672 [NCBI, ExPASy, EBI, Israel, Japan]
Maya-Nunez G., Zenteno J.C., Ulloa-Aguirre A., Kofman-Alfaro S., Mendez J.P.;
"A recurrent missense mutation in the KAL gene in patients with X-linked Kallmann's syndrome.";
J. Clin. Endocrinol. Metab. 83:1650-1653(1998).
[10]
VARIANT KAL1 ARG-172, AND VARIANT ILE-534.
DOI=10.1210/jc.86.4.1532; PubMed=11297579 [NCBI, ExPASy, EBI, Israel, Japan]
Oliveira L.M.B., Seminara S.B., Beranova M., Hayes F.J., Valkenburgh S.B., Schipani E., Costa E.M.F., Latronico A.C., Crowley W.F. Jr., Vallejo M.;
"The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.";
J. Clin. Endocrinol. Metab. 86:1532-1538(2001).
[11]
CHARACTERIZATION OF VARIANTS KAL1 LYS-267; LYS-514 AND LEU-517.
DOI=10.1093/hmg/ddh309; PubMed=15471890 [NCBI, ExPASy, EBI, Israel, Japan]
Cariboni A., Pimpinelli F., Colamarino S., Zaninetti R., Piccolella M., Rumio C., Piva F., Rugarli E.I., Maggi R.;
"The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons.";
Hum. Mol. Genet. 13:2781-2791(2004).
[12]
VARIANT KAL1 TYR-163, AND VARIANT ILE-534.
DOI=10.1210/jc.2003-030476; PubMed=15001591 [NCBI, ExPASy, EBI, Israel, Japan]
Sato N., Katsumata N., Kagami M., Hasegawa T., Hori N., Kawakita S., Minowada S., Shimotsuka A., Shishiba Y., Yokozawa M., Yasuda T., Nagasaki K., Hasegawa D., Hasegawa Y., Tachibana K., Naiki Y., Horikawa R., Tanaka T., Ogata T.;
"Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.";
J. Clin. Endocrinol. Metab. 89:1079-1088(2004).
[13]
VARIANTS KAL1 PRO-262 AND ARG-571.
DOI=10.1002/humu.9298; PubMed=15605412 [NCBI, ExPASy, EBI, Israel, Japan]
Albuisson J., Pecheux C., Carel J.-C., Lacombe D., Leheup B., Lapuzina P., Bouchard P., Legius E., Matthijs G., Wasniewska M., Delpech M., Young J., Hardelin J.-P., Dode C.;
"Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).";
Hum. Mutat. 25:98-99(2005).
[14]
VARIANT KAL1 LEU-396.
DOI=10.1371/journal.pgen.0020175; PubMed=17054399 [NCBI, ExPASy, EBI, Israel, Japan]
Dode C., Teixeira L., Levilliers J., Fouveaut C., Bouchard P., Kottler M.-L., Lespinasse J., Lienhardt-Roussie A., Mathieu M., Moerman A., Morgan G., Murat A., Toublanc J.-E., Wolczynski S., Delpech M., Petit C., Young J., Hardelin J.-P.;
"Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.";
PLoS Genet. 2:1648-1652(2006).
[15]
VARIANT KAL1 SER-304, AND VARIANT ILE-534.
DOI=10.1111/j.1365-2265.2006.02702.x; PubMed=17223984 [NCBI, ExPASy, EBI, Israel, Japan]
Versiani B.R., Trarbach E., Koenigkam-Santos M., dos Santos A.C., Elias L.L.K., Moreira A.C., Latronico A.C., de Castro M.;
"Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.";
Clin. Endocrinol. (Oxf.) 66:173-179(2007).
[16]
VARIANT KAL1 CYS-163 DEL, AND VARIANTS MET-666 AND HIS-668.
DOI=10.1093/molehr/gal108; PubMed=17213338 [NCBI, ExPASy, EBI, Israel, Japan]
Bhagavath B., Xu N., Ozata M., Rosenfield R.L., Bick D.P., Sherins R.J., Layman L.C.;
"KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans.";
Mol. Hum. Reprod. 13:165-170(2007).
Comments
  • FUNCTION: May be an adhesion-like molecule with anti-protease activity.
  • SUBCELLULAR LOCATION: Cell surface.
  • PTM: N-glycosylated.
  • DISEASE: Defects in KAL1 are the cause of Kallmann syndrome type 1 (KAL1) [MIM:308700]; also known as hypogonadotropic hypogonadism and anosmia. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In some patients other developmental anomalies can be present, which include renal agenesis, cleft lip and/or palate, selective tooth agenesis, and bimanual synkinesis. In some cases anosmia may be absent or inconspicuous.
  • SIMILARITY: Contains 4 fibronectin type-III domains.
  • SIMILARITY: Contains 1 WAP domain.
  • WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=KAL1";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M97252; AAA59202.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
S60085; AAB20108.1; ALT_SEQ; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
X60299; CAA42841.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC005184; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
AC006062; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
AC096511; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
X82034; CAA57554.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00011174; -.
PIR A40351; A40351.
S17982; S17982.
RefSeq NP_000207.2; -.
UniGene Hs.521869
3D structure databases
PDB
1ZLG; X-ray; -; A=24-680.[ExPASy / RCSB / EBI]
PDBsum 1ZLG; -.
ModBase P23352.
PTM databases
PhosphoSite P23352; -.
Organism-specific databases
GeneCards GC0XM008456; -.
H-InvDB HIX0056280; -.
HIX0056736; -.
HGNC HGNC:6211; KAL1.
GenAtlas KAL1.
MIM 308700; gene+phenotype. [NCBI / EBI]
Orphanet 478; Kallmann syndrome.
PharmGKB PA134871999; -.
Gene expression databases
ArrayExpress P23352; -.
Bgee P23352; -.
CleanEx HS_KAL1; -.
GermOnline ENSG00000011201; Homo sapiens.
Ontologies
GO
GO:0009986; Cellular component: cell surface (inferred from electronic annotation from UniProtKB-SubCell).
GO:0005615; Cellular component: extracellular space (traceable author statement from ProtInc).
GO:0005578; Cellular component: proteinaceous extracellular matrix (traceable author statement from ProtInc).
GO:0005201; Molecular function: extracellular matrix structural constituent (traceable author statement from ProtInc).
GO:0005515; Molecular function: protein binding (inferred from electronic annotation from UniProtKB-KW).
GO:0004867; Molecular function: serine-type endopeptidase inhibitor activity (inferred from electronic annotation from UniProtKB-KW).
GO:0007411; Biological process: axon guidance (traceable author statement from ProtInc).
GO:0007155; Biological process: cell adhesion (traceable author statement from ProtInc).
GO:0006935; Biological process: chemotaxis (traceable author statement from ProtInc).
QuickGo view.
Family and domain databases
InterPro IPR015874; 4-disulphide_core.
IPR008957; Fibronectin_typ-III-like_fold.
IPR003961; FN_III.
IPR018069; Whey_acidic_4-diS_core_CS.
IPR008197; Whey_acidic_protein_4-diS_core.
Graphical view of domain structure.
Gene3D G3DSA:2.60.40.30; FN_III-like; 2.
G3DSA:4.10.75.10; Whey_acidic_protein_4-diS_core; 1.
Pfam PF00041; fn3; 3.
PF00095; WAP; 1.
Pfam graphical view of domain structure.
PRINTS PR00003; 4DISULPHCORE.
SMART SM00060; FN3; 4.
SM00217; WAP; 1.
SMART graphical view of domain structure.
PROSITE PS50853; FN3; 4.
PS51390; WAP; 1.
PROSITE graphical view of domain structure (profiles).
Proteomic databases
PRIDE P23352; -.
Genome annotation databases
Ensembl ENSG00000011201; Homo sapiens. [Contig view]
GeneID 3730; -.
KEGG hsa:3730; -.
NMPDR fig|9606.3.peg.32416; -.
Phylogenomic databases
HOGENOM P23352; -.
HOVERGEN P23352; -.
OMA P23352; EPCKESG.
Other
NextBio 14603; -.
SOURCE KAL1; Homo sapiens.
ProtoNet P23352.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Cell adhesion; Disease mutation; Glycoprotein; Hypogonadotropic hypogonadism; Kallmann syndrome; Polymorphism; Protease inhibitor; Repeat; Serine protease inhibitor; Signal.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
SIGNAL   1    24  24     Potential. 
CHAIN   25   680  656     Anosmin-1. PRO_0000041395
DOMAIN   127   176  50     WAP. 
DOMAIN   183   284  102     Fibronectin type-III 1. 
DOMAIN   290   394  105     Fibronectin type-III 2. 
DOMAIN   425   520  96     Fibronectin type-III 3. 
DOMAIN   547   652  106     Fibronectin type-III 4. 
CARBOHYD   71    71        N-linked (GlcNAc...) (Potential). 
CARBOHYD   209   209        N-linked (GlcNAc...) (Potential). 
CARBOHYD   300   300        N-linked (GlcNAc...) (Potential). 
CARBOHYD   470   470        N-linked (GlcNAc...) (Potential). 
CARBOHYD   553   553        N-linked (GlcNAc...) (Potential). 
CARBOHYD   564   564        N-linked (GlcNAc...) (Potential). 
VARIANT   163   163  1     C -> Y (in KAL1). VAR_031012 
VARIANT   163   163  1     Missing (in KAL1). VAR_031011
VARIANT   172   172  1     C -> R (in KAL1). VAR_031013 
VARIANT   262   262  1     R -> P (in KAL1). VAR_031014 
VARIANT   267   267  1     N -> K (in KAL1; loss of effect on the migratory activity of GnRH neurons). VAR_007720 
VARIANT   304   304  1     N -> S (in KAL1). VAR_031015 
VARIANT   396   396  1     S -> L (in KAL1). VAR_031016 
VARIANT   514   514  1     E -> K (in KAL1; loss of effect on the migratory activity of GnRH neurons). VAR_012742 
VARIANT   517   517  1     F -> L (in KAL1; loss of effect on the migratory activity of GnRH neurons). VAR_031017 
VARIANT   534   534  1     V -> I (in dbSNP:rs808119 [NCBI]). VAR_007721 
VARIANT   571   571  1     W -> R (in KAL1). VAR_031018 
VARIANT   666   666  1     K -> M. VAR_031019 
VARIANT   668   668  1     R -> H. VAR_031020 
CONFLICT   48    48        R -> P (in Ref. 1; AAA59202, 3; CAA42841 and 5; CAA57554). 
CONFLICT   70    71        NN -> VR (in Ref. 5; CAA57554). 
CONFLICT   373   373        E -> K (in Ref. 3; CAA42841). 
CONFLICT   540   540        A -> R (in Ref. 3; CAA42841). 
Sequence information
Length: 680 AA [This is the length of the unprocessed precursor] Molecular weight: 76112 Da [This is the MW of the unprocessed precursor] CRC64: F491FE94FFD9250E [This is a checksum on the sequence]
        10         20         30         40         50         60 
MVPGVPGAVL TLCLWLAASS GCLAAGPGAA AARRLDESLS AGSVQRARCA SRCLSLQITR 

        70         80         90        100        110        120 
ISAFFQHFQN NGSLVWCQNH KQCSKCLEPC KESGDLRKHQ CQSFCEPLFP KKSYECLTSC 

       130        140        150        160        170        180 
EFLKYILLVK QGDCPAPEKA SGFAAACVES CEVDNECSGV KKCCSNGCGH TCQVPKTLYK 

       190        200        210        220        230        240 
GVPLKPRKEL RFTELQSGQL EVKWSSKFNI SIEPVIYVVQ RRWNYGIHPS EDDATHWQTV 

       250        260        270        280        290        300 
AQTTDERVQL TDIRPSRWYQ FRVAAVNVHG TRGFTAPSKH FRSSKDPSAP PAPANLRLAN 

       310        320        330        340        350        360 
STVNSDGSVT VTIVWDLPEE PDIPVHHYKV FWSWMVSSKS LVPTKKKRRK TTDGFQNSVI 

       370        380        390        400        410        420 
LEKLQPDCDY VVELQAITYW GQTRLKSAKV SLHFTSTHAT NNKEQLVKTR KGGIQTQLPF 

       430        440        450        460        470        480 
QRRRPTRPLE VGAPFYQDGQ LQVKVYWKKT EDPTVNRYHV RWFPEACAHN RTTGSEASSG 

       490        500        510        520        530        540 
MTHENYIILQ DLSFSCKYKV TVQPIRPKSH SKAEAVFFTT PPCSALKGKS HKPVGCLGEA 

       550        560        570        580        590        600 
GHVLSKVLAK PENLSASFIV QDVNITGHFS WKMAKANLYQ PMTGFQVTWA EVTTESRQNS 

       610        620        630        640        650        660 
LPNSIISQSQ ILPSDHYVLT VPNLRPSTLY RLEVQVLTPG GEGPATIKTF RTPELPPSSA 

       670        680 
HRSHLKHRHP HHYKPSPERY 

P23352 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!